Achieving Quiescence with Fluocinolone Implants

Freia McGregor; Andrew D Dick; Tomas Burke

doi:10.1159/000513221

Achieving Quiescence with Fluocinolone Implants

Case Rep Ophthalmol. 2021 May 10;12(2):356-362. doi: 10.1159/000513221. eCollection 2021 May-Aug.

Authors

Freia McGregor¹, Andrew D Dick¹, Tomas Burke¹

Affiliation

¹ Bristol Eye Hospital, Bristol, United Kingdom.

Abstract

Persistent anterior uveitis causing cystoid macular oedema may necessitate either intraocular or systemic immunosuppression. This case report highlights how a newly licenced treatment, fluocinolone acetonide (Iluvien^®, Alimera Sciences Ltd., England, UK) achieves quiescence in refractory and steroid-dependent disease and in the presence of an acute relapse.

Keywords: Fluocinolone acetonide; Intraocular inflammation; Uveitis.

Publication types

Case Reports